Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes

Key Points

• Sarcopenic obesity is significantly linked to higher mortality risk in Type 2 diabetes patients aged 40-75.
• Patients aged 40-75 years showed a notable increase in mortality risk associated with sarcopenic obesity, while those over 75 experienced risks tied to sarcopenia alone.
• This observational analysis focused on Japanese individuals, highlighting varied risks based on age strata.
• The findings suggest the need for targeted interventions addressing sarcopenic obesity, especially in younger diabetes patients.